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Evidence Flowers: Improving accessibility and engagement with evidence based guidance.  
Babatunde OO, Jordan JL, van der Windt D, Dziedzic K, Tan V, Chew-Graham CA, Protheroe J. 
Background: NICE Clinical guidelines are based on large volumes of synthesised evidence, but the 
technical language, reading time, as well as identification of  core guidance in the guideline, may 
deter engagement and subsequent application into to practice. Therefore, we explore the feasibility of 
summarising core guidance information within NICE clinical guidelines for osteoarthritis and 
depression visually as “evidence flowers”.  
Aims: To suggest a simple, visual and novel method of expressing core guideline recommendations to 
improve stakeholder accessibility and engagement with clinical guidelines. 
Methods: Two recent NICE guidelines (NICE depression guideline 2009; NICE OA guideline 2014) 
were selected and evidence flowers representing core recommendations of the guidelines were 
created. Strength of the research evidence behind each recommendation, graded within the guidelines 
based on the GRADE system (http://www.gradeworkinggroup.org/), was indicated by using different 
coloured ‘petals’ in the evidence flowers. Narrative summary of the information on the petal was kept 
brief and written in plain language. NICE working group members gave informal feedback on 
agreement of the evidence flowers with the original evidence in the guidelines. Stakeholders’ (non-
academic GPs, Allied Health Professionals and health service managers) engagement with the clinical 
guideline was assessed via structured questionnaires before and after seeing the evidence flowers. 
Accessibility and acceptability of the evidence flowers were also evaluated. 
Results: Evidence flowers for the two clinical guidelines will be presented with comments on 
stakeholders’ accessibility and engagement with the guideline recommendations. Feedback and 
comments on agreement with original evidence by guideline working group members will also be 
discussed. 
Conclusions: Evidence flowers are novel and visually stimulating for collating and presenting 
evidence to stakeholders and policy makers. We propose that they are used in conjunction with 
clinical guideline core statements to promote and facilitate stakeholder engagement with evidence as 
well as bridge the gap between research evidence and clinical practice. 
 
 
 
 
